Cargando…

Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.

Total concentrations of follicle stimulating hormone (FSH) were evaluated in daily urine samples from conceptive and nonconceptive menstrual cycles by measurement of the FSH beta subunit following treatment of the samples to dissociate the FSH heterodimer. Samples were self-collected by normal subje...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Q, Overstreet, J W, Todd, H, Nakajima, S T, Stewart, D R, Lasley, B L
Formato: Texto
Lenguaje:English
Publicado: 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1470195/
https://www.ncbi.nlm.nih.gov/pubmed/9347902
_version_ 1782127776104448000
author Qiu, Q
Overstreet, J W
Todd, H
Nakajima, S T
Stewart, D R
Lasley, B L
author_facet Qiu, Q
Overstreet, J W
Todd, H
Nakajima, S T
Stewart, D R
Lasley, B L
author_sort Qiu, Q
collection PubMed
description Total concentrations of follicle stimulating hormone (FSH) were evaluated in daily urine samples from conceptive and nonconceptive menstrual cycles by measurement of the FSH beta subunit following treatment of the samples to dissociate the FSH heterodimer. Samples were self-collected by normal subjects during cycles in which daily blood samples also were obtained. Daily blood and urine specimens were collected prospectively from 10 subject in conceptive cycles, which led to normal pregnancies, and from 10 subjects with bilateral tubal ligations to provide control samples form nonconceptive cycles. Mean serum and urinary FSH concentration profiles wer parallel in both groups following ovulation and during he first 9 days of the luteal phase. Mean values for both serum and urinary FSH rose significantly above the postovulatory baseline by 10-12 days following the midcycle luteinizing hormone (LH) peak in nonconceptive cycles, but did not rise at any time following ovulation during conceptive cycles. Following regression analysis of the changing FSH concentration between days 9-14 post-LH surge in conceptive cycles, a slope of </= 0.02 ng FHS/mg creatinine/day was selected as a cutoff point to identify conceptive cycles. There was a high concordance between the day of LH peak in serum and the day of FSH peak in urine. Therefore, in applying the algorithm, the day of FSH peak in urine was used to determine the days for which the FSH slope would be calculated, i.e., days 9-14 post-FSH peak in urine. The sensitivity and specificity of the change in urinary FSH concentrations to detect pregnancy in a different set of 55 cycles were found to 88.9% and 89.3%, respectively. All six cases of early fetal loss in the sample set were correctly identified. These results suggest that urinary FSH can be used as an additional biomarker for the verification of early pregnancy in prospective epidemiological studies in which early fetal loss is a suspected outcome.
format Text
id pubmed-1470195
institution National Center for Biotechnology Information
language English
publishDate 1997
record_format MEDLINE/PubMed
spelling pubmed-14701952006-06-01 Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion. Qiu, Q Overstreet, J W Todd, H Nakajima, S T Stewart, D R Lasley, B L Environ Health Perspect Research Article Total concentrations of follicle stimulating hormone (FSH) were evaluated in daily urine samples from conceptive and nonconceptive menstrual cycles by measurement of the FSH beta subunit following treatment of the samples to dissociate the FSH heterodimer. Samples were self-collected by normal subjects during cycles in which daily blood samples also were obtained. Daily blood and urine specimens were collected prospectively from 10 subject in conceptive cycles, which led to normal pregnancies, and from 10 subjects with bilateral tubal ligations to provide control samples form nonconceptive cycles. Mean serum and urinary FSH concentration profiles wer parallel in both groups following ovulation and during he first 9 days of the luteal phase. Mean values for both serum and urinary FSH rose significantly above the postovulatory baseline by 10-12 days following the midcycle luteinizing hormone (LH) peak in nonconceptive cycles, but did not rise at any time following ovulation during conceptive cycles. Following regression analysis of the changing FSH concentration between days 9-14 post-LH surge in conceptive cycles, a slope of </= 0.02 ng FHS/mg creatinine/day was selected as a cutoff point to identify conceptive cycles. There was a high concordance between the day of LH peak in serum and the day of FSH peak in urine. Therefore, in applying the algorithm, the day of FSH peak in urine was used to determine the days for which the FSH slope would be calculated, i.e., days 9-14 post-FSH peak in urine. The sensitivity and specificity of the change in urinary FSH concentrations to detect pregnancy in a different set of 55 cycles were found to 88.9% and 89.3%, respectively. All six cases of early fetal loss in the sample set were correctly identified. These results suggest that urinary FSH can be used as an additional biomarker for the verification of early pregnancy in prospective epidemiological studies in which early fetal loss is a suspected outcome. 1997-08 /pmc/articles/PMC1470195/ /pubmed/9347902 Text en
spellingShingle Research Article
Qiu, Q
Overstreet, J W
Todd, H
Nakajima, S T
Stewart, D R
Lasley, B L
Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.
title Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.
title_full Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.
title_fullStr Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.
title_full_unstemmed Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.
title_short Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.
title_sort total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and periimplantation spontaneous abortion.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1470195/
https://www.ncbi.nlm.nih.gov/pubmed/9347902
work_keys_str_mv AT qiuq totalurinaryfolliclestimulatinghormoneasabiomarkerfordetectionofearlypregnancyandperiimplantationspontaneousabortion
AT overstreetjw totalurinaryfolliclestimulatinghormoneasabiomarkerfordetectionofearlypregnancyandperiimplantationspontaneousabortion
AT toddh totalurinaryfolliclestimulatinghormoneasabiomarkerfordetectionofearlypregnancyandperiimplantationspontaneousabortion
AT nakajimast totalurinaryfolliclestimulatinghormoneasabiomarkerfordetectionofearlypregnancyandperiimplantationspontaneousabortion
AT stewartdr totalurinaryfolliclestimulatinghormoneasabiomarkerfordetectionofearlypregnancyandperiimplantationspontaneousabortion
AT lasleybl totalurinaryfolliclestimulatinghormoneasabiomarkerfordetectionofearlypregnancyandperiimplantationspontaneousabortion